MDSpire - Summary
Feature

Breast Cancer Recurrence Remains Low—Even After 10 Years—With Radiotherapy Tailored to Patient’s Individual Risk

“The results of our study show that tailoring the extent of radiotherapy according to how well the chemotherapy has worked to treat cancer in the lymph nodes leads to very low and reassuring recurrenc...

Share

A Dutch study presented at EBCC15 reveals that tailored radiotherapy following chemotherapy effectively minimizes breast cancer recurrence. Conducted over 10 years with 848 patients, the research found that those with no remaining cancer in lymph nodes might avoid radiotherapy altogether, significantly reducing side effects. Dr. Fleur Mauritz highlights that this personalized approach leads to reassuringly low recurrence rates, with further investigations planned on risk factors to optimize radiotherapy strategies in the future.

Original Source(s)

Breast Cancer Recurrence Remains Low—Even After 10 Years—With Radiotherapy Tailored to Patient’s Individual Risk

  • by The ASCO Post Staff

  • March 30, 2026

Related Content

Radiotherapy May Reduce Risk of Lymphedema in Patients With Breast Cancer More Effectively Than Surgery

These results come from the pilot phase of the phase III ADARNAT randomized international clinical trial, which is investigating whether axillary radiotherapy has a lower risk of lymphedema than axill...

AI As Collaborator in Cancer Research and in Clinical Care

Last October, the Cancer AI Alliance (CAIA) announced the launch of its collaborative artificial intelligence (AI) platform powered by federated learning to train AI models with millions of de-identif...

Metabolic Subtypes of Nasopharyngeal Carcinoma and Response to Treatment

In a Chinese study reported in the Journal of Clinical Oncology, Huang et al developed a classification for metabolic subtypes of nasopharyngeal carcinoma that may help identify patients benefiting mo...